Drug Companies

Peter R. Breggin, MD – Antidepressants & Suicide – Congressional Testimony

 “The Drug industry is the best profit maker of all manufacturing industries in this country and has been for decades. The old line medicine makers hit the top of the charts year after year. The bosses of those firms talk about research cost and drug development costs, but they do not discuss what that money brings in return. The money spent for research does not match the money spent for advertising. Advertising is the biggest item of their budgets. According to the Senate Committee Report No. 448, prepared by Judiciary, 87th Congress, the average outlay for research was about 10% of the sales dollar and for advertising about 25%. And of course, if a medicine maker does find a new, useful medicine, it is given patent for seventeen years plenty of time to recoup it outlay and make a nice profit….Of course you will find that not only are medicines makers too greedy to protect their patients, doctors add to the problem. In 1997 the Associated Press said the FDA admitted “too few doctors” read the inscriptions on medicine package warning of adverse effects and had ordered such warnings to be printed in larger and bolder type so doctors would read them. Seven medicines pulled in 1997 were stilled being prescribed by doctors in 1999. The same article stated that 2,000,000 million persons are hospitalized every year because of adverse drug reactions, and of these 100,000 die”

The Lies The Drug Companies tell to sell how they are manipulating us (Big Pham) 1:14:06


Full Bill Moyer’s Journal Interview with Melody Petersen on PBS   (19:00 minutes). Melody Petersen talks with Bill Moyers about her new book OUR DAILY MEDS, and how drug companies market medication. Click on the link Below:


Interview Segments Below:








A bitter pill for Big Pharma
The Los Angeles Times
January 27 , 2008

Drugs are hyped by ghostwriters, not sound science
The Chicago Tribune

From Idenifying Medical Malpractice by Jack Schroder

Dr. Peter Breggin M.D. Wrote in his book Medication Madness:

“Drug Companies go to great lengths to protect their products and in the process they keep doctors and the public in the dark about many of their adverse effects”.

Classic case of this was in our own FDA when it with held information in our opinion this is an example:

Cymbalta Suicide Data Withheld by FDA

Apr 16, 2008 | Parker Waichman Alonso LLP http://www.yourlawyer.com/

Cymbalta, an antidepressant made by Eli Lilly, has been linked to suicides. Although suicide is sometimes the tragic outcome of depression, some of those who have committed suicide while taking Cymbalta were not being treated for depression – or for any other mental illness. Unfortunately, despite reports of suicides not linked to depression, the Food & Drug Administration(FDA) has been slow to act on Cymbalta, and has actually concealed information on some suicides that occurred during clinical trials conducted by Eli Lilly, the drug’s maker.

Cymbalta – known generically as Duloxetine – was approved by the FDA in 2004 to treat depression and peripheral neuropathy. By the end of that year, Cymbalta sales topped $61.3 million. At some point—the date is undisclosed—Eli Lilly began testing Duloxetine under the brand name Yentreve as a treatment for urinary incontinence. In 2004, Traci Johnson, a healthy 19-year-old college student volunteer enrolled in a Cymbalta/Yentreve trial hung herself by a scarf from a shower rod in Lilly’s Indianapolis, IN laboratory while withdrawing from the drug. Johnson had not been diagnosed with depression, and had been screened for mental health issues prior to being accepted into the trial.

Eli Lilly has claimed that Johnson’s tragic death was an isolated incident. Still, the FDA ordered Eli Lilly to stop accepting new volunteers for the study and to have continuing participants evaluated by an independent psychiatrist and sign new consent forms. But in another Cymbalta trial of 4,124 depressed patients just weeks later, four more participants committed suicide. In 2005, Eli Lilly stopped seeking approval for Yentreve in the US. The company did not say why the drug was not approved, nor was it required to do so by the FDA.

The publicity surrounding the Johnson suicide raised concerns among researchers and physicians about Cymbalta’s safety. Some went to the FDA looking for answers, but the agency was silent. The FDA said that the data from the clinical trials in question represented a “trade secret” that could not be released as Yentreve was never approved. This might be a perfectly acceptable reason for drug not on the market, but Eli Lilly was conducting these clinical trials to gain approval for new uses of Duloxetine. Meanwhile, millions of people were already taking it as Cymbalta, and had no idea it had been associated with these suicides. Unfortunately, the FDA didn’t seem concerned that it might be protecting so-called trade secrets at the expense of patient safety.

Cymbalta – under the name Yentreve- was already being sold as a urinary incontinence treatment overseas, where a disturbing pattern of suicides emerged. According to overseas data, twice the expected number of suicide attempts among middle aged women were seen with the drug– 400 per 100,000 person-years versus a baseline of 160 per 100,000 person-years. Other sources also recorded disturbing incidents of Cymbalta suicides.

By presenting the FDA with a Freedom of Information Act request on behalf of “Independent on Sunday,” reporter Jeanne Lenzer learned of 41 deaths and 13 suicides associated with Cymbalta, which did not include Johnson’s or the four suicides that followed. The data obtained by Lenzer didn’t include the other suicides because those clinical trials fell under the FDA’s trade secret rationalization.

Antidepressants like Cymbalta have been linked to hundreds of suicides. In most cases, drug makers blame those incidents on the depression itself. But the Cymbalta suicides indicates there is more to the story. Unfortunately, because the FDA has insisted on protecting Eli Lilly, the whole story might never be known.

Websites documents Cymbalta withdrawal trauma anecdotally (1,000’s of Entries)

So check out the websites they are an eye opener about Cymbalta withdrawal these are facts Elli Lilly does not want you to see or know:

What Winners Do:





http://www.depressionforums.org/forums/Cymbalta-Withdrawal-It-s-Pretty- t13148.html

Point of Return:


Third Party Withdraw assistance:

Why should you pay for assistance????

Depression Hurts Cymbalta Hurts More!!!


You Tube Video Concise (2:30) description of the trama and effects



(non Eli Lilly Supported) drug rep page – The reps are aware of the issue

If the reps know then do you not have the right to know?

Eli Lilly and Their Product Cymbalta Exposed, a rigged depression Test on Web MD

BNET exposed how WebMD’s online test for depression is rigged for profit:


“Feeling depressed? Cheer yourself up by taking WebMD’s comical new depression test.

It’s sponsored by Eli Lilly (LLY) — maker of the antidepressant Cymbalta – so they must know what they’re talking about, right?

In fact, no matter which of the 10 answers you choose on the test, the result comes out the same:

You may be at risk for major depression.”

But that’s just the beginning. A number of questions about just how ‘independent’ a source WebMD is have since surfaced, and the answers are not what you’d expect.



FDA Says Promotions, Statements by 4 Drug Makers are Misleading

Jan 13, 2010 | Parker Waichman Alonso LLP

Four drug makers have received Food & Drug Administration (FDA) warning letters for misleading promotions and statements about their drugs. The drugs cited by the letters include the diabetes drug Byetta, which is marketed jointly by Amylin and Eli Lilly, Eli Lilly’s antidepressant Cymbalta, Bayer’s birth control implant Mirena, and and Cephalon’s Treanda, a lymphoma treatment.The Byetta letter cited statements made by an Eli Lilly representative at the…

FDA Says Promotions, Statements by 4 Drug Makers are Misleading »

Check out the court cases involving drug companies:


Ex Drug Reprensative of 15 Year Tells All on the Drug Companies

Gwen Olsen is an ex drug reprensative with the experience of 15 years selling drugs to doctors, she was one top drug representatives in her field, that quit after having an adverse reaction to antidepressants. She has has after this made several videos and podcasts and is now doing lectures and writing books about big drug companies and how they are not in the business of health for patients well being but just wealth for themselves, and their share holders.






© 2020